Luoxin Pharmaceuticals Group Stock announced that the company and relevant personnel recently received the "Decisions on Ordering Rectification Measures for Luoxin Pharmaceuticals Group Co., Ltd." and the "Decisions on Issuing Warning Letters to Liu Zhenteng, Liu Baoqi, Chen Xian, and Han Fengsheng" issued by Shandong Securities Regulatory Bureau. After investigation, the company has the following problems: inaccurate disclosure of revenue amounts; incomplete disclosure of some important contract terms; some related transactions were not examined or disclosed. Shandong Securities Regulatory Bureau decided to take administrative supervisory measures of ordering rectification for the company, issue warning letters to relevant responsible persons, and record relevant information in the integrity archives of securities and futures markets.
罗欣药业：因信披不准确等被山东证监局责令改正
Luoxin Pharmaceuticals Group Stock: Ordered to rectify by Shandong Securities Regulatory Bureau due to inaccurate disclosure.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.